ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression

Omar Abdel-Wahab, Mazhar Adli, Lindsay M. LaFave, Jie Gao, Todd Hricik, Alan H. Shih, Suveg Pandey, Jay P. Patel, Young Rock Chung, Richard Koche, Fabiana Perna, Xinyang Zhao, Jordan E. Taylor, Christopher Y. Park, Martin Carroll, Ari Melnick, Stephen D Nimer, Jacob D. Jaffe, Iannis Aifantis, Bradley E. BernsteinRoss L. Levine

Research output: Contribution to journalArticle

300 Citations (Scopus)

Abstract

Recurrent somaticASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome. Despite the genetic and clinical data implicating ASXL1 mutations in myeloid malignancies, the mechanisms of transformation by ASXL1 mutations are not understood. Here, we identify that ASXL1 mutations result in loss of polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) tri-methylation. Through integration of microarray data with genome-wide histone modification ChIP-Seq data, we identify targets of ASXL1 repression, including the posterior HOXA cluster that is known to contribute to myeloid transformation. We demonstrate that ASXL1 associates with the PRC2, and that loss of ASXL1 in vivo collaborates with NRASG12D to promote myeloid leukemogenesis.

Original languageEnglish
Pages (from-to)180-193
Number of pages14
JournalCancer Cell
Volume22
Issue number2
DOIs
StatePublished - Aug 14 2012

Fingerprint

Polycomb Repressive Complex 2
Mutation
Genes
Histone Code
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Histones
Methylation
Lysine
Neoplasms
Genome

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Oncology

Cite this

Abdel-Wahab, O., Adli, M., LaFave, L. M., Gao, J., Hricik, T., Shih, A. H., ... Levine, R. L. (2012). ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression. Cancer Cell, 22(2), 180-193. https://doi.org/10.1016/j.ccr.2012.06.032

ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression. / Abdel-Wahab, Omar; Adli, Mazhar; LaFave, Lindsay M.; Gao, Jie; Hricik, Todd; Shih, Alan H.; Pandey, Suveg; Patel, Jay P.; Chung, Young Rock; Koche, Richard; Perna, Fabiana; Zhao, Xinyang; Taylor, Jordan E.; Park, Christopher Y.; Carroll, Martin; Melnick, Ari; Nimer, Stephen D; Jaffe, Jacob D.; Aifantis, Iannis; Bernstein, Bradley E.; Levine, Ross L.

In: Cancer Cell, Vol. 22, No. 2, 14.08.2012, p. 180-193.

Research output: Contribution to journalArticle

Abdel-Wahab, O, Adli, M, LaFave, LM, Gao, J, Hricik, T, Shih, AH, Pandey, S, Patel, JP, Chung, YR, Koche, R, Perna, F, Zhao, X, Taylor, JE, Park, CY, Carroll, M, Melnick, A, Nimer, SD, Jaffe, JD, Aifantis, I, Bernstein, BE & Levine, RL 2012, 'ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression', Cancer Cell, vol. 22, no. 2, pp. 180-193. https://doi.org/10.1016/j.ccr.2012.06.032
Abdel-Wahab O, Adli M, LaFave LM, Gao J, Hricik T, Shih AH et al. ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression. Cancer Cell. 2012 Aug 14;22(2):180-193. https://doi.org/10.1016/j.ccr.2012.06.032
Abdel-Wahab, Omar ; Adli, Mazhar ; LaFave, Lindsay M. ; Gao, Jie ; Hricik, Todd ; Shih, Alan H. ; Pandey, Suveg ; Patel, Jay P. ; Chung, Young Rock ; Koche, Richard ; Perna, Fabiana ; Zhao, Xinyang ; Taylor, Jordan E. ; Park, Christopher Y. ; Carroll, Martin ; Melnick, Ari ; Nimer, Stephen D ; Jaffe, Jacob D. ; Aifantis, Iannis ; Bernstein, Bradley E. ; Levine, Ross L. / ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression. In: Cancer Cell. 2012 ; Vol. 22, No. 2. pp. 180-193.
@article{7aa1eeab76c148499651319e56925248,
title = "ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression",
abstract = "Recurrent somaticASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome. Despite the genetic and clinical data implicating ASXL1 mutations in myeloid malignancies, the mechanisms of transformation by ASXL1 mutations are not understood. Here, we identify that ASXL1 mutations result in loss of polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) tri-methylation. Through integration of microarray data with genome-wide histone modification ChIP-Seq data, we identify targets of ASXL1 repression, including the posterior HOXA cluster that is known to contribute to myeloid transformation. We demonstrate that ASXL1 associates with the PRC2, and that loss of ASXL1 in vivo collaborates with NRASG12D to promote myeloid leukemogenesis.",
author = "Omar Abdel-Wahab and Mazhar Adli and LaFave, {Lindsay M.} and Jie Gao and Todd Hricik and Shih, {Alan H.} and Suveg Pandey and Patel, {Jay P.} and Chung, {Young Rock} and Richard Koche and Fabiana Perna and Xinyang Zhao and Taylor, {Jordan E.} and Park, {Christopher Y.} and Martin Carroll and Ari Melnick and Nimer, {Stephen D} and Jaffe, {Jacob D.} and Iannis Aifantis and Bernstein, {Bradley E.} and Levine, {Ross L.}",
year = "2012",
month = "8",
day = "14",
doi = "10.1016/j.ccr.2012.06.032",
language = "English",
volume = "22",
pages = "180--193",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "2",

}

TY - JOUR

T1 - ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression

AU - Abdel-Wahab, Omar

AU - Adli, Mazhar

AU - LaFave, Lindsay M.

AU - Gao, Jie

AU - Hricik, Todd

AU - Shih, Alan H.

AU - Pandey, Suveg

AU - Patel, Jay P.

AU - Chung, Young Rock

AU - Koche, Richard

AU - Perna, Fabiana

AU - Zhao, Xinyang

AU - Taylor, Jordan E.

AU - Park, Christopher Y.

AU - Carroll, Martin

AU - Melnick, Ari

AU - Nimer, Stephen D

AU - Jaffe, Jacob D.

AU - Aifantis, Iannis

AU - Bernstein, Bradley E.

AU - Levine, Ross L.

PY - 2012/8/14

Y1 - 2012/8/14

N2 - Recurrent somaticASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome. Despite the genetic and clinical data implicating ASXL1 mutations in myeloid malignancies, the mechanisms of transformation by ASXL1 mutations are not understood. Here, we identify that ASXL1 mutations result in loss of polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) tri-methylation. Through integration of microarray data with genome-wide histone modification ChIP-Seq data, we identify targets of ASXL1 repression, including the posterior HOXA cluster that is known to contribute to myeloid transformation. We demonstrate that ASXL1 associates with the PRC2, and that loss of ASXL1 in vivo collaborates with NRASG12D to promote myeloid leukemogenesis.

AB - Recurrent somaticASXL1 mutations occur in patients with myelodysplastic syndrome, myeloproliferative neoplasms, and acute myeloid leukemia, and are associated with adverse outcome. Despite the genetic and clinical data implicating ASXL1 mutations in myeloid malignancies, the mechanisms of transformation by ASXL1 mutations are not understood. Here, we identify that ASXL1 mutations result in loss of polycomb repressive complex 2 (PRC2)-mediated histone H3 lysine 27 (H3K27) tri-methylation. Through integration of microarray data with genome-wide histone modification ChIP-Seq data, we identify targets of ASXL1 repression, including the posterior HOXA cluster that is known to contribute to myeloid transformation. We demonstrate that ASXL1 associates with the PRC2, and that loss of ASXL1 in vivo collaborates with NRASG12D to promote myeloid leukemogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84865152223&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865152223&partnerID=8YFLogxK

U2 - 10.1016/j.ccr.2012.06.032

DO - 10.1016/j.ccr.2012.06.032

M3 - Article

C2 - 22897849

AN - SCOPUS:84865152223

VL - 22

SP - 180

EP - 193

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 2

ER -